Your browser doesn't support javascript.
loading
Show: 20 | 50 | 100
Results 1 - 20 de 84
Filter
1.
Genes Dev ; 38(5-6): 253-272, 2024 04 17.
Article in English | MEDLINE | ID: mdl-38565249

ABSTRACT

Oncogenic activation of MYC in cancers predominantly involves increased transcription rather than coding region mutations. However, MYC-dependent lymphomas frequently acquire point mutations in the MYC phosphodegron, including at threonine 58 (T58), where phosphorylation permits binding via the FBW7 ubiquitin ligase triggering MYC degradation. To understand how T58 phosphorylation functions in normal cell physiology, we introduced an alanine mutation at T58 (T58A) into the endogenous c-Myc locus in the mouse germline. While MYC-T58A mice develop normally, lymphomas and myeloid leukemias emerge in ∼60% of adult homozygous T58A mice. We found that primitive hematopoietic progenitor cells from MYC-T58A mice exhibit aberrant self-renewal normally associated with hematopoietic stem cells (HSCs) and up-regulate a subset of MYC target genes important in maintaining stem/progenitor cell balance. In lymphocytes, genomic occupancy by MYC-T58A was increased at all promoters compared with WT MYC, while genes differentially expressed in a T58A-dependent manner were significantly more proximal to MYC-bound enhancers. MYC-T58A lymphocyte progenitors exhibited metabolic alterations and decreased activation of inflammatory and apoptotic pathways. Our data demonstrate that a single point mutation stabilizing MYC is sufficient to skew target gene expression, producing a profound gain of function in multipotential hematopoietic progenitors associated with self-renewal and initiation of lymphomas and leukemias.


Subject(s)
F-Box-WD Repeat-Containing Protein 7 , Hematologic Neoplasms , Lymphoma , Proto-Oncogene Proteins c-myc , Animals , Mice , Germ Cells/metabolism , Hematopoietic Stem Cells/metabolism , Point Mutation , Proto-Oncogene Proteins c-myc/genetics , Proto-Oncogene Proteins c-myc/metabolism , F-Box-WD Repeat-Containing Protein 7/metabolism
2.
Cell ; 164(4): 668-80, 2016 Feb 11.
Article in English | MEDLINE | ID: mdl-26871632

ABSTRACT

Mouse embryonic stem cells (ESCs) are maintained in a naive ground state of pluripotency in the presence of MEK and GSK3 inhibitors. Here, we show that ground-state ESCs express low Myc levels. Deletion of both c-myc and N-myc (dKO) or pharmacological inhibition of Myc activity strongly decreases transcription, splicing, and protein synthesis, leading to proliferation arrest. This process is reversible and occurs without affecting pluripotency, suggesting that Myc-depleted stem cells enter a state of dormancy similar to embryonic diapause. Indeed, c-Myc is depleted in diapaused blastocysts, and the differential expression signatures of dKO ESCs and diapaused epiblasts are remarkably similar. Following Myc inhibition, pre-implantation blastocysts enter biosynthetic dormancy but can progress through their normal developmental program after transfer into pseudo-pregnant recipients. Our study shows that Myc controls the biosynthetic machinery of stem cells without affecting their potency, thus regulating their entry and exit from the dormant state.


Subject(s)
Embryonic Stem Cells/cytology , Genes, myc , Proto-Oncogene Proteins c-myc/genetics , Animals , Blastocyst/metabolism , Cell Proliferation , Embryo, Mammalian/cytology , Embryo, Mammalian/metabolism , Embryonic Stem Cells/metabolism , Female , Gene Knockout Techniques , Male , Mice , Mice, Inbred C57BL
3.
Cell ; 160(3): 365-6, 2015 Jan 29.
Article in English | MEDLINE | ID: mdl-25635453

ABSTRACT

The Myc proto-oncogene has been intensively studied in tumorigenesis and development. A new paper in Cell reports the role of Myc as a determinant of mammalian longevity. Myc heterozygous mice exhibit extended lifespans resulting from alterations in multiple cellular processes distinct from those observed in other longevity models.


Subject(s)
Proto-Oncogene Proteins c-myc/genetics , Proto-Oncogene Proteins c-myc/metabolism , Animals , Female , Male
4.
Mol Cell ; 73(3): 533-546.e4, 2019 02 07.
Article in English | MEDLINE | ID: mdl-30595435

ABSTRACT

Quiescence is a stress-resistant state in which cells reversibly exit the cell cycle and suspend most processes. Quiescence is essential for stem cell maintenance, and its misregulation is implicated in tumor formation. One of the hallmarks of quiescent cells is highly condensed chromatin. Because condensed chromatin often correlates with transcriptional silencing, it has been hypothesized that chromatin compaction represses transcription during quiescence. However, the technology to test this model by determining chromatin structure within cells at gene resolution has not previously been available. Here, we use Micro-C XL to map chromatin contacts at single-nucleosome resolution genome-wide in quiescent Saccharomyces cerevisiae cells. We describe chromatin domains on the order of 10-60 kilobases that, only in quiescent cells, are formed by condensin-mediated loops. Condensin depletion prevents the compaction of chromatin within domains and leads to widespread transcriptional de-repression. Finally, we demonstrate that condensin-dependent chromatin compaction is conserved in quiescent human fibroblasts.


Subject(s)
Adenosine Triphosphatases/metabolism , Cellular Senescence , Chromatin Assembly and Disassembly , Chromatin/genetics , DNA-Binding Proteins/metabolism , Fibroblasts/enzymology , Multiprotein Complexes/metabolism , Saccharomyces cerevisiae Proteins/metabolism , Saccharomyces cerevisiae/enzymology , Transcription, Genetic , Adenosine Triphosphatases/genetics , Binding Sites , Cell Proliferation , Cells, Cultured , Chromatin/metabolism , DNA-Binding Proteins/genetics , Gene Expression Regulation, Fungal , Humans , Multiprotein Complexes/genetics , Protein Binding , Saccharomyces cerevisiae/genetics , Saccharomyces cerevisiae/growth & development , Saccharomyces cerevisiae Proteins/genetics , Time Factors
5.
Genes Dev ; 33(17-18): 1252-1264, 2019 09 01.
Article in English | MEDLINE | ID: mdl-31395740

ABSTRACT

Although MAX is regarded as an obligate dimerization partner for MYC, its function in normal development and neoplasia is poorly defined. We show that B-cell-specific deletion of Max has a modest effect on B-cell development but completely abrogates Eµ-Myc-driven lymphomagenesis. While Max loss affects only a few hundred genes in normal B cells, it leads to the global down-regulation of Myc-activated genes in premalignant Eµ-Myc cells. We show that the balance between MYC-MAX and MNT-MAX interactions in B cells shifts in premalignant B cells toward a MYC-driven transcriptional program. Moreover, we found that MAX loss leads to a significant reduction in MYC protein levels and down-regulation of direct transcriptional targets, including regulators of MYC stability. This phenomenon is also observed in multiple cell lines treated with MYC-MAX dimerization inhibitors. Our work uncovers a layer of Myc autoregulation critical for lymphomagenesis yet partly dispensable for normal development.


Subject(s)
Basic-Leucine Zipper Transcription Factors/genetics , Basic-Leucine Zipper Transcription Factors/metabolism , Carcinogenesis/genetics , Gene Expression Regulation, Neoplastic , Lymphoma/genetics , Proto-Oncogene Proteins c-myc/genetics , Proto-Oncogene Proteins c-myc/metabolism , Active Transport, Cell Nucleus , Animals , Carcinogenesis/drug effects , Cell Line, Tumor , Enzyme Inhibitors/pharmacology , Gene Deletion , Gene Expression Regulation, Neoplastic/drug effects , Humans , Indoles/pharmacology , Kynurenine/genetics , Kynurenine/metabolism , Lymphoma/physiopathology , Mice , Organoids/growth & development , Organoids/physiopathology , Oximes/pharmacology , Sulfonamides/pharmacology
7.
Cell ; 142(3): 480-93, 2010 Aug 06.
Article in English | MEDLINE | ID: mdl-20691906

ABSTRACT

The Myc oncoprotein family comprises transcription factors that control multiple cellular functions and are widely involved in oncogenesis. Here we report the identification of Myc-nick, a cytoplasmic form of Myc generated by calpain-dependent proteolysis at lysine 298 of full-length Myc. Myc-nick retains conserved Myc box regions but lacks nuclear localization signals and the bHLHZ domain essential for heterodimerization with Max and DNA binding. Myc-nick induces alpha-tubulin acetylation and altered cell morphology by recruiting histone acetyltransferase GCN5 to microtubules. During muscle differentiation, while the levels of full-length Myc diminish, Myc-nick and acetylated alpha-tubulin levels are increased. Ectopic expression of Myc-nick accelerates myoblast fusion, triggers the expression of myogenic markers, and permits Myc-deficient fibroblasts to transdifferentiate in response to MyoD. We propose that the cleavage of Myc by calpain abrogates the transcriptional inhibition of differentiation by full-length Myc and generates Myc-nick, a driver of cytoplasmic reorganization and differentiation.


Subject(s)
Proto-Oncogene Proteins c-myc/metabolism , Tubulin/metabolism , Acetylation , Animals , Cell Differentiation , Cell Line, Tumor , Cells, Cultured , Cytosol/metabolism , Humans , Mice , Rats
8.
PLoS Biol ; 19(10): e3001085, 2021 10.
Article in English | MEDLINE | ID: mdl-34669700

ABSTRACT

Male germ cell (GC) production is a metabolically driven and apoptosis-prone process. Here, we show that the glucose-sensing transcription factor (TF) MAX-Like protein X (MLX) and its binding partner MondoA are both required for male fertility in the mouse, as well as survival of human tumor cells derived from the male germ line. Loss of Mlx results in altered metabolism as well as activation of multiple stress pathways and GC apoptosis in the testes. This is concomitant with dysregulation of the expression of male-specific GC transcripts and proteins. Our genomic and functional analyses identify loci directly bound by MLX involved in these processes, including metabolic targets, obligate components of male-specific GC development, and apoptotic effectors. These in vivo and in vitro studies implicate MLX and other members of the proximal MYC network, such as MNT, in regulation of metabolism and differentiation, as well as in suppression of intrinsic and extrinsic death signaling pathways in both spermatogenesis and male germ cell tumors (MGCTs).


Subject(s)
Apoptosis , Basic Helix-Loop-Helix Leucine Zipper Transcription Factors/metabolism , Glucose/metabolism , Spermatogenesis , Stress, Physiological , Animals , Base Sequence , Cell Survival , Exons/genetics , Fertility , Gene Deletion , Gene Expression Profiling , Gene Expression Regulation , Gene Targeting , Lipid Metabolism , Male , Mice, Knockout , Models, Biological , Neoplasms, Germ Cell and Embryonal/pathology , Principal Component Analysis , RNA/genetics , RNA/metabolism , Repressor Proteins/metabolism , Reproduction , Sertoli Cells/metabolism , Spermatogenesis/genetics , Spermatozoa/metabolism , Testicular Neoplasms/pathology , Testis/metabolism , Transcription Factors/metabolism , Transcription, Genetic
9.
Genes Dev ; 30(23): 2637-2648, 2016 12 01.
Article in English | MEDLINE | ID: mdl-28007786

ABSTRACT

Myc plays critical roles in the self-renewal division of various stem cell types. In spermatogonial stem cells (SSCs), Myc controls SSC fate decisions because Myc overexpression induces enhanced self-renewal division, while depletion of Max, a Myc-binding partner, leads to meiotic induction. However, the mechanism by which Myc acts on SSC fate is unclear. Here we demonstrate a critical link between Myc/Mycn gene activity and glycolysis in SSC self-renewal. In SSCs, Myc/Mycn are regulated by Foxo1, whose deficiency impairs SSC self-renewal. Myc/Mycn-deficient SSCs not only undergo limited self-renewal division but also display diminished glycolytic activity. While inhibition of glycolysis decreased SSC activity, chemical stimulation of glycolysis or transfection of active Akt1 or Pdpk1 (phosphoinositide-dependent protein kinase 1 ) augmented self-renewal division, and long-term SSC cultures were derived from a nonpermissive strain that showed limited self-renewal division. These results suggested that Myc-mediated glycolysis is an important factor that increases the frequency of SSC self-renewal division.


Subject(s)
Cell Self Renewal/genetics , Gene Expression Regulation, Developmental/genetics , Glycolysis/genetics , N-Myc Proto-Oncogene Protein/metabolism , Proto-Oncogene Proteins c-myc/metabolism , Spermatogonia/cytology , Stem Cells/metabolism , 3-Phosphoinositide-Dependent Protein Kinases/metabolism , Animals , Cell Division/genetics , Cell Proliferation/genetics , Gene Knockout Techniques , Male , Mice , Mice, Inbred C57BL , N-Myc Proto-Oncogene Protein/genetics , Proto-Oncogene Proteins c-myc/genetics , RNA Splicing Factors/metabolism , Stem Cells/enzymology
10.
Genes Dev ; 30(11): 1289-99, 2016 06 01.
Article in English | MEDLINE | ID: mdl-27298335

ABSTRACT

Small cell lung cancer (SCLC) is a devastating neuroendocrine carcinoma. MYCL (L-Myc) is frequently amplified in human SCLC, but its roles in SCLC progression are poorly understood. We isolated preneoplastic neuroendocrine cells from a mouse model of SCLC and found that ectopic expression of L-Myc, c-Myc, or N-Myc conferred tumor-forming capacity. We focused on L-Myc, which promoted pre-rRNA synthesis and transcriptional programs associated with ribosomal biogenesis. Deletion of Mycl in two genetically engineered models of SCLC resulted in strong suppression of SCLC. The high degree of suppression suggested that L-Myc may constitute a therapeutic target for a broad subset of SCLC. We then used an RNA polymerase I inhibitor to target rRNA synthesis in an autochthonous Rb/p53-deleted mouse SCLC model and found significant tumor inhibition. These data reveal that activation of RNA polymerase I by L-Myc and other MYC family proteins provides an axis of vulnerability for this recalcitrant cancer.


Subject(s)
Lung Neoplasms/enzymology , Lung Neoplasms/genetics , Proto-Oncogene Proteins c-myc/metabolism , RNA Polymerase I/metabolism , Small Cell Lung Carcinoma/enzymology , Small Cell Lung Carcinoma/genetics , Animals , Animals, Genetically Modified , Benzothiazoles/pharmacology , Disease Models, Animal , Enzyme Activation/drug effects , Enzyme Inhibitors/pharmacology , Gene Silencing , Lung Neoplasms/physiopathology , Mice , Naphthyridines/pharmacology , Proto-Oncogene Proteins c-myc/genetics , RNA Polymerase I/antagonists & inhibitors , Ribosomes/metabolism , Small Cell Lung Carcinoma/physiopathology , Tumor Burden/drug effects , Tumor Cells, Cultured
11.
Proc Natl Acad Sci U S A ; 117(9): 4885-4893, 2020 03 03.
Article in English | MEDLINE | ID: mdl-32071205

ABSTRACT

We previously found that MYCL is required by a Batf3-dependent classical dendritic cell subset (cDC1) for optimal CD8 T cell priming, but the underlying mechanism has remained unclear. The MAX-binding proteins encompass a family of transcription factors with overlapping DNA-binding specificities, conferred by a C-terminal basic helix-loop-helix domain, which mediates heterodimerization. Thus, regulation of transcription by these factors is dependent on divergent N-terminal domains. The MYC family, including MYCL, has actions that are reciprocal to the MXD family, which is mediated through the recruitment of higher-order activator and repressor complexes, respectively. As potent proto-oncogenes, models of MYC family function have been largely derived from their activity at supraphysiological levels in tumor cell lines. MYC and MYCN have been studied extensively, but empirical analysis of MYCL function had been limited due to highly restricted, lineage-specific expression in vivo. Here we observed that Mycl is expressed in immature cDC1s but repressed on maturation, concomitant with Mxd1 induction in mature cDC1s. We hypothesized that MYCL and MXD1 regulate a shared, but reciprocal, transcriptional program during cDC1 maturation. In agreement, immature cDC1s in Mycl-/- -deficient mice exhibited reduced expression of genes that regulate core biosynthetic processes. Mature cDC1s from Mxd1-/- mice exhibited impaired ability to inhibit the transcriptional signature otherwise supported by MYCL. The present study reveals LMYC and MXD1 as regulators of a transcriptional program that is modulated during the maturation of Batf3-dependent cDC1s.


Subject(s)
Basic Helix-Loop-Helix Leucine Zipper Transcription Factors/metabolism , Dendritic Cells/metabolism , Proto-Oncogene Proteins c-myc/metabolism , Repressor Proteins/metabolism , Transcription Factors/metabolism , Animals , Basic Helix-Loop-Helix Leucine Zipper Transcription Factors/genetics , Basic-Leucine Zipper Transcription Factors/genetics , Cell Line, Tumor , Gene Expression Regulation, Neoplastic , Genes, myc , Homeostasis , Inflammation , Mice , Mice, Knockout , Neoplasms/genetics , Protein Binding , Proto-Oncogene Proteins c-myc/genetics , Repressor Proteins/genetics
12.
Genes Dev ; 29(23): 2475-89, 2015 Dec 01.
Article in English | MEDLINE | ID: mdl-26584623

ABSTRACT

Metabolic stress and changes in nutrient levels modulate many aspects of skeletal muscle function during aging and disease. Growth factors and cytokines secreted by skeletal muscle, known as myokines, are important signaling factors, but it is largely unknown whether they modulate muscle growth and differentiation in response to nutrients. Here, we found that changes in glucose levels increase the activity of the glucose-responsive transcription factor MLX (Max-like protein X), which promotes and is necessary for myoblast fusion. MLX promotes myogenesis not via an adjustment of glucose metabolism but rather by inducing the expression of several myokines, including insulin-like growth factor 2 (IGF2), whereas RNAi and dominant-negative MLX reduce IGF2 expression and block myogenesis. This phenotype is rescued by conditioned medium from control muscle cells and by recombinant IGF2, which activates the myogenic kinase Akt. Importantly, MLX-null mice display decreased IGF2 induction and diminished muscle regeneration in response to injury, indicating that the myogenic function of MLX is manifested in vivo. Thus, glucose is a signaling molecule that regulates myogenesis and muscle regeneration via MLX/IGF2/Akt signaling.


Subject(s)
Muscle Development/genetics , Muscle, Skeletal/cytology , Nuclear Proteins/metabolism , Signal Transduction , Transcription Factors/metabolism , Acetylation , Animals , Basic Helix-Loop-Helix Leucine Zipper Transcription Factors , Cell Line , Gene Expression Regulation, Developmental/genetics , Glucose/metabolism , Histones/metabolism , Insulin-Like Growth Factor II/genetics , Insulin-Like Growth Factor II/metabolism , Mice , Mice, Inbred C57BL , Muscle, Skeletal/physiology , Regeneration
13.
Genes Dev ; 28(7): 689-707, 2014 Apr 01.
Article in English | MEDLINE | ID: mdl-24696454

ABSTRACT

Evasion of apoptosis is critical in Myc-induced tumor progression. Here we report that cancer cells evade death under stress by activating calpain-mediated proteolysis of Myc. This generates Myc-nick, a cytoplasmic, transcriptionally inactive cleavage product of Myc. We found conversion of Myc into Myc-nick in cell lines and tissues derived from multiple cancers. In colon cancer, the production of Myc-nick is enhanced under stress conditions such as hypoxia and nutrient deprivation. Under these conditions, ectopic expression of Myc-nick promotes anchorage-independent growth and cell survival at least in part by promoting autophagy. Myc-nick also delays colon cancer cell death after treatment with chemotherapeutic drugs such as etoposide, cisplatin, and imatinib. Furthermore, colon cancer cells expressing a cleavage-resistant form of Myc undergo extensive apoptosis but are rescued by overexpression of Myc-nick. We also found that ectopic expression of Myc-nick results in the induction of the actin-bundling protein fascin, formation of filopodia, and increased cell motility-all mediators of tumor metastasis. Myc-nick-induced survival, autophagy, and motility require Myc box II (MBII), a region of Myc-nick that recruits acetyltransferases that in turn modify cytoplasmic proteins, including α-tubulin and ATG3. Our results suggest that Myc-nick-induced survival and motility contribute to colon cancer progression and metastasis.


Subject(s)
Colonic Neoplasms/physiopathology , Gene Expression Regulation, Neoplastic , Proto-Oncogene Proteins c-myc/genetics , Proto-Oncogene Proteins c-myc/metabolism , Stress, Physiological/physiology , Acetylation , Animals , Antineoplastic Agents/pharmacology , Autophagy/genetics , Cell Hypoxia/physiology , Cell Line, Tumor , Cell Survival/drug effects , Cell Survival/genetics , Colonic Neoplasms/pathology , Cytoplasm/metabolism , Gene Expression Profiling , Genomic Instability/genetics , Humans , Intercellular Signaling Peptides and Proteins/metabolism , Mice , Proteolysis
14.
J Biol Chem ; 295(7): 2001-2017, 2020 02 14.
Article in English | MEDLINE | ID: mdl-31919096

ABSTRACT

The MAX network transcriptional repressor (MNT) is an MXD family transcription factor of the basic helix-loop-helix (bHLH) family. MNT dimerizes with another transcriptional regulator, MYC-associated factor X (MAX), and down-regulates genes by binding to E-boxes. MAX also dimerizes with MYC, an oncogenic bHLH transcription factor. Upon E-box binding, the MYC-MAX dimer activates gene expression. MNT also binds to the MAX dimerization protein MLX (MLX), and MNT-MLX and MNT-MAX dimers co-exist. However, all MNT functions have been attributed to MNT-MAX dimers, and no functions of the MNT-MLX dimer have been described. MNT's biological role has been linked to its function as a MYC oncogene modulator, but little is known about its regulation. We show here that MNT localizes to the nucleus of MAX-expressing cells and that MNT-MAX dimers bind and repress the MNT promoter, an effect that depends on one of the two E-boxes on this promoter. In MAX-deficient cells, MNT was overexpressed and redistributed to the cytoplasm. Interestingly, MNT was required for cell proliferation even in the absence of MAX. We show that in MAX-deficient cells, MNT binds to MLX, but also forms homodimers. RNA-sequencing experiments revealed that MNT regulates the expression of several genes even in the absence of MAX, with many of these genes being involved in cell cycle regulation and DNA repair. Of note, MNT-MNT homodimers regulated the transcription of some genes involved in cell proliferation. The tight regulation of MNT and its functionality even without MAX suggest a major role for MNT in cell proliferation.


Subject(s)
Basic Helix-Loop-Helix Leucine Zipper Transcription Factors/genetics , Repressor Proteins/genetics , Transcription, Genetic , Amino Acid Sequence/genetics , Animals , Basic Helix-Loop-Helix Leucine Zipper Transcription Factors/chemistry , Cell Proliferation/genetics , Gene Expression Regulation/genetics , Gene Regulatory Networks/genetics , Helix-Loop-Helix Motifs/genetics , Humans , Promoter Regions, Genetic , Protein Multimerization/genetics , Proto-Oncogene Proteins c-myc/chemistry , Proto-Oncogene Proteins c-myc/genetics , Repressor Proteins/chemistry
15.
Proc Natl Acad Sci U S A ; 113(37): E5481-90, 2016 09 13.
Article in English | MEDLINE | ID: mdl-27566402

ABSTRACT

MYC-nick is a cytoplasmic, transcriptionally inactive member of the MYC oncoprotein family, generated by a proteolytic cleavage of full-length MYC. MYC-nick promotes migration and survival of cells in response to chemotherapeutic agents or withdrawal of glucose. Here we report that MYC-nick is abundant in colonic and intestinal tumors derived from mouse models with mutations in the Wnt, TGF-ß, and PI3K pathways. Moreover, MYC-nick is elevated in colon cancer cells deleted for FBWX7, which encodes the major E3 ligase of full-length MYC frequently mutated in colorectal cancers. MYC-nick promotes the migration of colon cancer cells assayed in 3D cultures or grown as xenografts in a zebrafish metastasis model. MYC-nick accelerates migration by activating the Rho GTPase Cdc42 and inducing fascin expression. MYC-nick, fascin, and Cdc42 are frequently up-regulated in cells present at the invasive front of human colorectal tumors, suggesting a coordinated role for these proteins in tumor migration.


Subject(s)
Carrier Proteins/genetics , Colorectal Neoplasms/genetics , Microfilament Proteins/genetics , Proto-Oncogene Proteins c-myc/genetics , Stomach Neoplasms/genetics , cdc42 GTP-Binding Protein/genetics , Animals , Cell Line, Tumor , Cell Movement/genetics , Colorectal Neoplasms/pathology , F-Box-WD Repeat-Containing Protein 7/genetics , Gene Expression Regulation, Neoplastic , Humans , Mice , Neoplasm Metastasis , Signal Transduction , Stomach Neoplasms/pathology , Transcriptional Activation/genetics , Zebrafish
16.
Biochim Biophys Acta ; 1849(5): 484-500, 2015 May.
Article in English | MEDLINE | ID: mdl-24857747

ABSTRACT

The transcription factor MYC and its related family members MYCN and MYCL have been implicated in the etiology of a wide spectrum of human cancers. Compared to other oncoproteins, such as RAS or SRC, MYC is unique because its protein coding region is rarely mutated. Instead, MYC's oncogenic properties are unleashed by regulatory mutations leading to unconstrained high levels of expression. Under both normal and pathological conditions MYC regulates multiple aspects of cellular physiology including proliferation, differentiation, apoptosis, growth and metabolism by controlling the expression of thousands of genes. How a single transcription factor exerts such broad effects remains a fascinating puzzle. Notably, MYC is part of a network of bHLHLZ proteins centered on the MYC heterodimeric partner MAX and its counterpart, the MAX-like protein MLX. This network includes MXD1-4, MNT, MGA, MONDOA and MONDOB proteins. With some exceptions, MXD proteins have been functionally linked to cell cycle arrest and differentiation, while MONDO proteins control cellular metabolism. Although the temporal expression patterns of many of these proteins can differ markedly they are frequently expressed simultaneously in the same cellular context, and potentially bind to the same, or similar DNA consensus sequence. Here we review the activities and interactions among these proteins and propose that the broad spectrum of phenotypes elicited by MYC deregulation is intimately connected to the functions and regulation of the other network members. Furthermore, we provide a meta-analysis of TCGA data suggesting that the coordinate regulation of the network is important in MYC driven tumorigenesis. This article is part of a Special Issue entitled: Myc proteins in cell biology and pathology.


Subject(s)
Basic Helix-Loop-Helix Leucine Zipper Transcription Factors/genetics , Basic-Leucine Zipper Transcription Factors/genetics , Neoplasms/genetics , Proto-Oncogene Proteins c-myc/genetics , Basic Helix-Loop-Helix Leucine Zipper Transcription Factors/metabolism , Carcinogenesis/genetics , Cell Transformation, Neoplastic/genetics , Gene Regulatory Networks , Humans , Neoplasms/pathology , Proteolysis , Proto-Oncogene Proteins c-myc/metabolism
17.
Development ; 140(23): 4776-87, 2013 Dec.
Article in English | MEDLINE | ID: mdl-24173801

ABSTRACT

The essential and highly conserved role of Myc in organismal growth and development is dependent on the control of Myc protein abundance. It is now well established that Myc levels are in part regulated by ubiquitin-dependent proteasomal degradation. Using a genetic screen for modifiers of Drosophila Myc (dMyc)-induced growth, we identified and characterized a ubiquitin-specific protease (USP), Puffyeye (Puf), as a novel regulator of dMyc levels and function in vivo. We show that puf genetically and physically interacts with dMyc and the ubiquitin ligase archipelago (ago) to modulate a dMyc-dependent cell growth phenotype, and that varying Puf levels in both the eye and wing phenocopies the effects of altered dMyc abundance. Puf containing point mutations within its USP enzymatic domain failed to alter dMyc levels and displayed no detectable phenotype, indicating the importance of deubiquitylating activity for Puf function. We find that dMyc induces Ago, indicating that dMyc triggers a negative-feedback pathway that is modulated by Puf. In addition to its effects on dMyc, Puf regulates both Ago and its cell cycle substrate Cyclin E. Therefore, Puf influences cell growth by controlling the stability of key regulatory proteins.


Subject(s)
DNA-Binding Proteins/metabolism , Drosophila Proteins/metabolism , Drosophila melanogaster/metabolism , F-Box Proteins/metabolism , Transcription Factors/metabolism , Ubiquitin-Specific Proteases/metabolism , Animals , Cell Proliferation , Cyclin E/metabolism , DNA-Binding Proteins/genetics , Drosophila Proteins/genetics , Drosophila melanogaster/genetics , Drosophila melanogaster/growth & development , Eye/growth & development , Eye/metabolism , Gene Expression Regulation, Developmental , Protein Processing, Post-Translational , RNA Interference , RNA, Small Interfering , Transcription Factors/genetics , Ubiquitin/metabolism , Ubiquitin-Specific Proteases/genetics , Wings, Animal/growth & development , Wings, Animal/metabolism
18.
Angew Chem Int Ed Engl ; 55(50): 15646-15650, 2016 12 12.
Article in English | MEDLINE | ID: mdl-27860107

ABSTRACT

The balance between metabolism and biomass is very important in biological systems; however, to date there has been no quantitative method to characterize the balance. In this methodological study, we propose to use the distribution of amino acids in different domains to investigate this balance. It is well known that endogenous or exogenous amino acids in a biological system are either metabolized or incorporated into free amino acids (FAAs) or proteome amino acids (PAAs). Using glycine (Gly) as an example, we demonstrate a novel method to accurately determine the amounts of amino acids in various domains using serum, urine, and cell samples. As expected, serum and urine had very different distributions of FAA- and PAA-Gly. Using Tet21N human neuroblastoma cells, we also found that Myc(oncogene)-induced metabolic reprogramming included a higher rate of metabolizing Gly, which provides additional evidence that the metabolism of proliferating cells is adapted to facilitate producing new cells. It is therefore anticipated that our method will be very valuable for further studies of the metabolism and biomass balance that will lead to a better understanding of human cancers.


Subject(s)
Glycine/metabolism , Metabolic Networks and Pathways , Neoplasms/metabolism , Proteome/metabolism , Amino Acids/analysis , Amino Acids/blood , Amino Acids/metabolism , Amino Acids/urine , Cell Line, Tumor , Cell Proliferation , Glycine/analysis , Glycine/blood , Glycine/urine , Humans , Models, Molecular , Neoplasms/blood , Neoplasms/urine , Proteome/analysis , Proteomics
19.
Analyst ; 140(8): 2726-34, 2015 Apr 21.
Article in English | MEDLINE | ID: mdl-25699545

ABSTRACT

Amino acids play essential roles in both metabolism and the proteome. Many studies have profiled free amino acids (FAAs) or proteins; however, few have connected the measurement of FAA with individual amino acids in the proteome. In this study, we developed a metabolomics method to comprehensively analyze amino acids in different domains, using two examples of different sample types and disease models. We first examined the responses of FAAs and insoluble-proteome amino acids (IPAAs) to the Myc oncogene in Tet21N human neuroblastoma cells. The metabolic and proteomic amino acid profiles were quite different, even under the same Myc condition, and their combination provided a better understanding of the biological status. In addition, amino acids were measured in 3 domains (FAAs, free and soluble-proteome amino acids (FSPAAs), and IPAAs) to study changes in serum amino acid profiles related to colon cancer. A penalized logistic regression model based on the amino acids from the three domains had better sensitivity and specificity than that from each individual domain. To the best of our knowledge, this is the first study to perform a combined analysis of amino acids in different domains, and indicates the useful biological information available from a metabolomics analysis of the protein pellet. This study lays the foundation for further quantitative tracking of the distribution of amino acids in different domains, with opportunities for better diagnosis and mechanistic studies of various diseases.


Subject(s)
Amino Acids/analysis , Metabolomics/methods , Adolescent , Adult , Aged , Aged, 80 and over , Cell Line, Tumor , Female , Humans , Male , Middle Aged , Young Adult
20.
Sci Rep ; 14(1): 5236, 2024 03 04.
Article in English | MEDLINE | ID: mdl-38433229

ABSTRACT

Meiosis is a specialized type of cell division that occurs physiologically only in germ cells. We previously demonstrated that MYC-associated factor X (MAX) blocks the ectopic onset of meiosis in embryonic and germline stem cells in culture systems. Here, we investigated the Max gene's role in mouse primordial germ cells. Although Max is generally ubiquitously expressed, we revealed that sexually undifferentiated male and female germ cells had abundant MAX protein because of their higher Max gene expression than somatic cells. Moreover, our data revealed that this high MAX protein level in female germ cells declined significantly around physiological meiotic onset. Max disruption in sexually undifferentiated germ cells led to ectopic and precocious expression of meiosis-related genes, including Meiosin, the gatekeeper of meiotic onset, in both male and female germ cells. However, Max-null male and female germ cells did not complete the entire meiotic process, but stalled during its early stages and were eventually eliminated by apoptosis. Additionally, our meta-analyses identified a regulatory region that supports the high Max expression in sexually undifferentiated male and female germ cells. These results indicate the strong connection between the Max gene and physiological onset of meiosis in vivo through dynamic alteration of its expression.


Subject(s)
Factor X , Meiosis , Animals , Female , Male , Mice , Apoptosis , Cell Cycle Checkpoints , Germ Cells , Meiosis/genetics
SELECTION OF CITATIONS
SEARCH DETAIL